ASHLEY MASON: Open Payments
NPI 1821694589 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,644 in 106 payments from 19 companies in 2025. Trend: 2023 $180 · 2024 $2,106 · 2025 $1,644
Food & beverage: $1,644
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $273 |
| ABBVIE INC. | 15 | $206 |
| Lundbeck LLC | 17 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $167 |
| Alkermes, Inc. | 6 | $115 |
| Supernus Pharmaceuticals, Inc. | 6 | $109 |
| Corium, LLC | 5 | $79 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Almatica Pharma LLC | 3 | $63 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Qelbree, Azstarys, Auvelity, LYBALVI, COBENFY.
Industry payments across MI — which companies pay providers there.
